Mitochondrial Fission in Neurodegeneration

Mitochondrial Fission in Neurodegeneration

Overview

Mitochondrial Fission in Neurodegeneration describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer's disease, Parkinson's disease, and related disorders. [@reddy2011]

Mitochondrial fission is the process by which mitochondria divide and fragment from an interconnected network into discrete organelles[1]. This dynamic process is essential for mitochondrial quality control, enabling the removal of damaged mitochondrial segments via mitophagy, distribution of mitochondria within [neurons](/entities/neurons), and adaptation to metabolic demands. Dysregulation of fission contributes to mitochondrial dysfunction, bioenergetic failure, and neuronal death in neurodegenerative diseases. [@mitochondrial2024]

Molecular Machinery of Mitochondrial Fission

DRP1 (Dynamin-Related Protein 1)

• Cytosolic GTPase that translocates to mitochondria during fission
• Forms ring-like structures around mitochondria constricting the membranes[1]
• Recruited by adaptor proteins on the outer mitochondrial membrane
• Post-translational modifications regulate its activity (phosphorylation, sumoylation, ubiquitination)

...

Mitochondrial Fission in Neurodegeneration

Overview

Mitochondrial Fission in Neurodegeneration describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer's disease, Parkinson's disease, and related disorders. [@reddy2011]

Mitochondrial fission is the process by which mitochondria divide and fragment from an interconnected network into discrete organelles[1]. This dynamic process is essential for mitochondrial quality control, enabling the removal of damaged mitochondrial segments via mitophagy, distribution of mitochondria within [neurons](/entities/neurons), and adaptation to metabolic demands. Dysregulation of fission contributes to mitochondrial dysfunction, bioenergetic failure, and neuronal death in neurodegenerative diseases. [@mitochondrial2024]

Molecular Machinery of Mitochondrial Fission

DRP1 (Dynamin-Related Protein 1)

• Cytosolic GTPase that translocates to mitochondria during fission
• Forms ring-like structures around mitochondria constricting the membranes[1]
• Recruited by adaptor proteins on the outer mitochondrial membrane
• Post-translational modifications regulate its activity (phosphorylation, sumoylation, ubiquitination)

Fission Proteins (FIS1, MFF, MiD49, MiD50)

• FIS1: Outer membrane protein serving as [DRP1](/proteins/drp1-protein) receptor
• MFF: Primary DRP1 receptor, essential for peroxisomal and mitochondrial fission
• MiD49/MiD50: Additional DRP1 receptors with tissue-specific expression

Endoplasmic Reticulum Contacts

• ER tubules wrap around mitochondria at fission sites
• Calcium signaling regulates ER-mitochondria contact formation
• Actin polymerization provides mechanical force for constriction

Mitochondrial Fission in Neurodegenerative Diseases

Alzheimer's Disease

• Increased fission in AD brains correlates with disease severity[2]
• [Aβ](/proteins/amyloid-beta) promotes DRP1 recruitment to mitochondria
• [Tau](/proteins/tau) pathology enhances fission through GSK3β-mediated DRP1 phosphorylation
• Excessive fission leads to mitochondrial fragmentation and energy deficits

Parkinson's Disease

• PINK1/Parkin pathway regulates fission as part of mitophagy[4]
• Mutations in PINK1 or PRKN cause early-onset PD with mitochondrial dysfunction
• DRP1 inhibitors show protective effects in PD models
• Dopaminergic neurons are particularly vulnerable to fission dysregulation

Amyotrophic Lateral Sclerosis

• SOD1 mutations alter mitochondrial dynamics toward fission
• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology disrupts DRP1 localization
• Increased fission in motor neurons precedes degeneration
• Fission inhibitors protect against ALS-related mitochondrial dysfunction

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin) promotes excessive fission
• DRP1 hyperactivity contributes to striatal neuron vulnerability
• Fis1 expression increased in HD models and patients
• Fission blockade reverses mitochondrial deficits in HD models

Therapeutic Implications

DRP1 Inhibitors

• Mdivi-1: Small molecule inhibitor of DRP1 GTPase activity[3]
• P110: Specific DRP1 inhibitor reducing fission without affecting fusion
• Concerns about long-term inhibition due to essential physiological functions

Fis1 Targeting

• Antisense oligonucleotide approaches to reduce Fis1 expression
• Small molecule modulators of Fis1-DRP1 interaction

Combination Strategies

| Approach | Rationale | Status |
|----------|-----------|--------|
| Fission inhibitors + mitophagy enhancers | Coordinate quality control | Preclinical |
| DRP1 inhibitors + metabolic modulators | Restore energy balance | Research |
| Fission + fusion balancing | Optimize dynamics | Experimental |

Assessment Methods

Imaging

• Electron microscopy: Direct visualization of mitochondrial morphology
• Live-cell fluorescence microscopy: Time-lapse analysis of fission events
• Super-resolution microscopy: Nanoscale fission site identification

Biochemical Markers

• DRP1 phosphorylation status (Ser616 vs Ser637)
• FIS1, MFF protein levels
• OPA1 long/short isoform ratio (fusion:fission balance)

Functional Assays

• Mitochondrial network analysis using skeletonization algorithms
• Mitochondrial size distribution quantification
• ATP production and mitochondrial membrane potential measurement

Balance: Fusion vs Fission

The dynamic equilibrium between fusion and fission determines mitochondrial morphology:

Fusion (MFN1/2 + OPA1) ←→ Fission (DRP1 + FIS1/MFF)

Disease-Associated Imbalances

| Disease | Primary Defect | Resulting Morphology |
|---------|---------------|---------------------|
| AD | Fission increase | Fragmented |
| PD | Variable | Fragmented |
| ALS | Fission increase | Fragmented |
| HD | Fission increase | Fragmented |

Therapeutic Goal

Restore optimal dynamics rather than completely blocking fission, as both fusion and fission are essential for mitochondrial health.

Research Gaps

Cell-type specificity: Understanding why specific neurons are vulnerable to fission defects

Temporal targeting: Optimal timing of intervention during disease progression

Delivery methods: Targeting fission modulators to the CNS

Biomarkers: Non-invasive markers of mitochondrial dynamics status

Detailed DRP1 Regulation Mechanisms

Post-Translational Modifications

DRP1 activity is tightly regulated by multiple post-translational modifications that integrate cellular signaling cues:

Phosphorylation:

• Ser616 (activation): Phosphorylated by CDK1/2 during mitosis and by ERK1/2 in response to growth factors[@chen2020]
• Ser637 (inhibition): Phosphorylated by PKA, dephosphorylation by calcineurin activates DRP1[@chen2020]
• Ser40 (inhibition): AMPK-mediated phosphorylation inhibits fission under energy stress

Sumoylation:

• SENP5-mediated sumoylation stabilizes DRP1 on mitochondria
• Promotes fission under stress conditions
• Dysregulated in AD and PD

Ubiquitination:

• VCP/p97-mediated extraction of DRP1 for degradation
• Parkin ubiquitinates DRP1 during mitophagy
• Mitochondrial quality control pathways intersect with fission machinery

Calcium and Calcineurin Signaling

Cytosolic calcium dynamics directly regulate mitochondrial fission:

• Elevated calcium activates calcineurin, which dephosphorylates DRP1 at Ser637
• Activated DRP1 translocates to mitochondria, promoting fission
• ER-mitochondria calcium transfer at MAMs (mitochondria-associated membranes) locally regulates fission
• Calcium dysregulation in neurodegenerative diseases hyperactivates this pathway

AMPK and Energy Sensing

AMPK monitors cellular energy status and regulates fission:

• Energy deficit (low ATP/AMP ratio) activates AMPK
• AMPK phosphorylates DRP1 at multiple sites to promote fission
• Fission enables mitochondrial turnover to restore energy balance
• In AD, impaired AMPK signaling contributes to defective fission[@chen2020]

ER-Mitochondria Contact Sites in Fission

Structural Basis

ER tubules physically wrap around mitochondria at fission sites[@youle2013]:

• ER-mitochondria contacts span 10-30 nm
• Multiple ER-mitochondria tethering proteins maintain contact
• Calcium signaling at these sites regulates fission machinery recruitment

Molecular Tethers

| Tether | Function | Disease Relevance |
|--------|----------|-------------------|
| VAPB-PTPIP51 | ER-mitochondria link | Disrupted in ALS |
| Mfn2 | Tethering + fusion regulator | Reduced in AD |
| IP3R-GRP75-VDAC | Calcium transfer | Dysregulated in PD |
| BAP31 | ER stress sensor | Activated in neurodegeneration |

Actin Polymerization

Force generation for membrane constriction:

• ER-associated actin polymerization provides mechanical force
• Myosin II recruitment to fission sites
• Formin-mediated actin nucleation at contact sites
• Actin depolymerization blocks fission independent of DRP1

Fission in Neuronal Compartments

Axonal Mitochondrial Fission

Neurons present unique fission requirements[@singh2024]:

• Mitochondria must be sized to traverse axonal diameters
• Fission enables axonal distribution and presynaptic targeting
• Synaptic activity modulates axonal fission rates
• Defects impair synaptic mitochondrial replenishment

Spatial regulation:

• Fission biased toward branch points and varicosities
• Local calcium signals trigger axonal fission
• Synaptic vesicle recycling zones are fission hotspots

Dendritic Fission Patterns

Dendritic mitochondria show compartment-specific fission:

• Spine-targeted mitochondria require fission for entry
• Branch point fission enables dendrite penetration
• Activity-dependent fission shapes spine mitochondrial content
• Dysregulated fission contributes to spine loss in AD

Synaptic Mitochondrial Fission

Presynaptic terminals have specialized fission dynamics:

• High energy demand at terminals requires dynamic fission
• Synaptic activity increases fission frequency
• Fission enables rapid mitochondrial replacement
• Synaptic mitochondrial deficits correlate with neurotransmission failure

Fission-Fusion Balance in Disease

OPA1-Mediated Fusion Control

OPA1 (optic atrophy 1) mediates mitochondrial fusion[@kumar2025]:

• Long OPA1 isoforms promote inner membrane fusion
• OPA1 cleavage by OMA1 produces short isoforms
• AD-related stress increases OPA1 cleavage
• Imbalanced OPA1 processing shifts equilibrium toward fission

Disease-Specific Imbalances

| Feature | AD | PD | ALS | HD |
|---------|----|----|-----|-----|
| DRP1 levels | ↑ | ↑/↔ | ↑↑ | ↑↑ |
| OPA1 cleavage | ↑ | ↑ | ↑ | ↑ |
| FIS1 expression | ↑ | ↑ | ↑ | ↑ |
| MFN1/2 levels | ↓ | ↓ | ↓ | ↓/↔ |
| Morphology | Fragmented | Variable | Fragmented | Fragmented |

Therapeutic Implications

Modulating the balance rather than absolute fission:

• Restoring fusion capacity alongside inhibiting excessive fission
• Combination approaches targeting both processes
• Cell-type specific targeting required
• Temporal considerations for intervention timing

Cardiolipin and Membrane Remodeling

Cardiolipin Externalization

Phospholipid dynamics regulate fission[@johnson2025]:

• Cardiolipin normally resides in inner mitochondrial membrane
• Externalization to outer membrane recruits DRP1
• Oxidative stress promotes cardiolipin externalization
• Barth syndrome-related cardiolipin defects impair fission

Membrane Curvature Sensing

Fission proteins sense membrane curvature:

• DRP1 PRE domains bind curved membranes
• INF2-formin complexes generate curvature
• Peripheral proteins shape fission sites
• Curvature defects contribute to disease phenotypes

Novel Therapeutic Approaches

Peptide-Based Inhibitors

• p110 peptide: Blocks DRP1-FIS1 interaction specifically
• DRP1-blocking peptides: Cell-penetrating fission inhibitors
• Mitochondrial-targeted peptides: Localized delivery to CNS

Gene Therapy Strategies

• CRISPR-dCas9 approaches to modulate DRP1 expression
• ASOs targeting DRP1 splice variants
• AAV-mediated delivery of dominant-negative DRP1
• miRNA-based fission regulation

Small Molecule Modulators

| Compound | Target | Status | Notes |
|----------|--------|--------|-------|
| Mdivi-1 | DRP1 GTPase | Preclinical | CNS delivery challenge |
| P110 | DRP1-FIS1 | Preclinical | More selective |
| Dynasore | DRP1 | Research | Broader dynamin inhibition |
| YY1-33 | DRP1 sumoylation | Experimental | Enhances sumoylation |

Combination Strategies

• Fission inhibitors + metabolic enhancers
• Fission modulation + antioxidant treatment
• Fission targeting + tau/α-synuclein clearance
• Fusion-promoting compounds alongside fission inhibitors

Clinical Development Pipeline

Recent progress has accelerated fission-targeted therapy development:

Preclinical Candidates:

• Drp1-ASO: Antisense oligonucleotides reducing DRP1 expression
• mitochondria-p110: Peptide disrupting DRP1-FIS1 binding
• HDL-DRP1: Mitochondria-penetrating DRP1 inhibitor

Translation Challenges:

• CNS delivery remains the primary barrier
• Acute vs chronic dosing considerations
• Selectivity for disease-associated fission vs physiological fission
• Biomarker development for target engagement

Emerging Approaches:

• Brain-penetrant small molecules (e.g., DDR1 inhibitors with DRP1 effects)
• Antibody-based targeting of mitochondrial proteins
• Cell-type specific delivery via AAV capsids
• Nanoparticle-based mitochondrial targeting

Biomarkers for Mitochondrial Fission Status

Blood-Based Markers

• Circulating cell-free mtDNA
• Mitochondrial-derived peptides
• Extracellular vesicle mitochondrial proteins
• Metabolic signatures in plasma

Imaging Biomarkers

• PET probes for mitochondrial function
• MR spectroscopy of mitochondrial metabolites
• Super-resolution microscopy of blood cell mitochondria
• Fluorescence-based fission reporters

Functional Assessments

• Platelet mitochondrial morphology
• Lymphoblast mitochondrial dynamics
• Seahorse assay for bioenergetics
• Mitochondrial stress test outcomes

Quantitative Assessment Methods

Morphological Analysis

Classical Metrics:

• Aspect ratio (length/width)
• Branching index
• Network connectivity
• Fragmentation index

Advanced Techniques:

• Super-resolution STED microscopy
• 3D electron microscopy reconstruction
• Live-cell STED imaging
• Machine learning-based classification

Molecular Markers

| Parameter | Measurement | Disease Relevance |
|-----------|------------|-------------------|
| DRP1 Ser616-P | Western blot/ELISA | Fission activation |
| DRP1 Ser637-P | Western blot/ELISA | Fission inhibition |
| OPA1 long/short ratio | Gel electrophoresis | Fusion capacity |
| FIS1 levels | qPCR/Western | Fission adaptor |
| MFF levels | qPCR/Western | Fission adaptor |

Functional Readouts

• Mitochondrial membrane potential (TMRE, JC-1)
• ATP/ADP ratio (bioluminescence)
• ROS production (MitoSOX)
• Calcium handling (Fura-2)
• Mitochondrial respiration (Seahorse)

Neurodegenerative Disease Context

Alzheimer's Disease Specific Mechanisms

Aβ-DRP1 Interaction:

• Aβ oligomers bind to DRP1 directly
• Aβ promotes DRP1 recruitment to mitochondria
• Aβ-induced ROS activate fission
• Synaptic mitochondria lose fission capacity

Tau-DRP1 Interaction[@manczak2024]:

• Phosphorylated tau binds DRP1
• Tau pathology increases fission frequency
• Synaptic mitochondrial loss precedes tau tangle formation
• DRP1 inhibition protects against Aβ toxicity

Therapeutic Implications:

• Dual targeting of Aβ and mitochondrial fission
• DRP1 inhibitors in early AD prevention
• Fission modulation alongside anti-amyloid therapies

Parkinson's Disease Specific Mechanisms

α-Synuclein-DRP1 Interaction[@zhang2025]:

• α-Synuclein oligomers bind TOM20
• α-Synuclein impairs mitochondrial protein import
• Mitochondrial stress promotes fission
• Fission failure leads to mitophagy impairment

PINK1-Parkin Pathway[@park2024]:

• PINK1 accumulates on damaged mitochondria
• Parkin ubiquitinates outer membrane proteins
• DRP1 is recruited for fission
• Fission enables mitophagy completion

Dopaminergic Neuron Vulnerability:

• High energy demand requires robust mitochondria
• Limited fission capacity in SNc neurons
• Age-related decline affects dopamine neurons first
• Fission modulators may protect vulnerable neurons

Animal Models and Experimental Systems

Genetic Models

| Model | Application | Key Findings |
|-------|-------------|--------------|
| Drp1 flox/flox + CamKII-Cre | Conditional KO | Fission required for neuronal survival |
| Drp1 heterozygous | Partial reduction | Improved mitochondrial morphology in AD models |
| Fis1 overexpression | Fission increase | Accelerated neurodegeneration |
| Mff knockout | Fission loss | Defective mitophagy, accumulation |

Pharmacological Models

• Mdivi-1 treatment: DRP1 inhibition in vivo
• CCCP treatment: Mitochondrial depolarization
• Oligomycin: ATP synthase inhibition
• Rotenone Complex I inhibition

iPSC-Derived Models

• Patient-derived neurons with mitochondrial mutations
• Isogenic controls for variant analysis
• Differentiated dopaminergic neurons from PD patients
• Cortical neurons from AD patients

Cellular Stress Response

Mitochondrial Dynamics in Stress

Oxidative Stress:

• ROS promote DRP1 activation
• Fission increases in response to oxidative damage
• Fragmentation is protective by isolating damaged segments
• Antioxidants reduce fission frequency

Energy Stress:

• AMPK activation promotes fission
• ATP depletion triggers fission for quality control
• Fission enables mitophagy under stress
• Metabolic compromise accelerates fission

Inflammatory Stress:

• Cytokines modulate DRP1 expression
• Microglial activation affects neuronal fission
• NF-κB regulates fission protein transcription
• Inflammasome activation intersects with dynamics

Apoptotic Pathways

• Cytochrome c release requires fission
• Fission enables proper apoptotic execution
• DRP1 cleavage by caspases in apoptosis
• Anti-apoptotic Bcl-2 family proteins regulate fission

Computational Models and Systems Biology

Network Analysis

• Mitochondrial dynamics is governed by ~50 proteins
• Systems biology models predict fission-fusion balance
• Machine learning identifies key regulatory nodes
• Protein-protein interaction networks reveal targets

Modeling Approaches

• Agent-based modeling of fission events
• Quantitative systems pharmacology models
• Single-cell dynamics analysis
• Population-level mitochondrial heterogeneity

Future Directions and Unresolved Questions

Key Knowledge Gaps

Why are specific neurons vulnerable? — SNc dopaminergic neurons have unique fission requirements

Optimal intervention timing — When during disease progression should fission be modulated?

Fission vs. fusion prioritization — Which process is more critical to target?

Cell-type specificity — Can we achieve neuron-specific targeting?

Biomarker development — Non-invasive markers of mitochondrial dynamics status

Promising Research Avenues

• Single-cell mitochondrial dynamics measurement
• In vivo mitochondrial fission imaging
• Brain-penetrant fission modulators
• Gene therapy for fission protein modulation
• Combination approaches with disease-modifying therapies

Recent Research Updates (2024-2026)

Recent advances have clarified the role of mitochondrial fission in neurodegeneration:

• DRP1 phosphorylation and neuronal vulnerability: Studies reveal that specific DRP1 phosphorylation sites (Ser616, Ser637) differentially regulate mitochondrial fission in neurons, with modulation offering therapeutic potential in Alzheimer's and Parkinson's disease[@kim2025].
• Mitochondrial fission in tauopathy: Research demonstrates that hyperphosphorylated tau interacts with DRP1, enhancing fission and contributing to synaptic mitochondrial loss in Alzheimer's disease[@manczak2024].
• [Alpha-synuclein](/proteins/alpha-synuclein) and mitochondrial dynamics: Pathological alpha-synuclein directly binds to mitochondrial proteins, including DRP1 and TOM20, disrupting fission/fusion balance and promoting neuronal death in Parkinson's disease[@zhang2025].
• Therapeutic targeting of fission machinery: Small molecule DRP1 inhibitors (like mdivi-1) have shown neuroprotective effects in preclinical models, though CNS delivery remains challenging[@reddy2024].
• Fission and mitophagy interplay: Recent work reveals that fission is a prerequisite for mitophagy, with defective fission leading to accumulation of dysfunctional mitochondria in neurodegenerative diseases[@liu2025].
• ALS pathogenesis: DRP1-mediated mitochondrial fission is elevated in ALS models and patient tissues, with excessive fission contributing to motor neuron vulnerability[@choi2024].
• Huntington's disease: Mitochondrial dynamics are severely disrupted in HD, with DRP1 hyperactivity contributing to striatal neuron death and fission inhibitors showing protective effects[@iyer2024].
• PINK1-Parkin pathway: New insights into how PINK1 and Parkin coordinate mitochondrial fission as part of the quality control cascade in PD[@park2024].

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial Dynamics Pathway](/mechanisms/mitochondrial-dynamics-pathway)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Mitophagy](/mechanisms/mitophagy)
• [DRP1 Protein](/proteins/drp1-protein)
• [OPA1 Protein](/proteins/opa1-protein)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References

[Youle RJ, Mitochondrial fission and fusion (2013)](https://pubmed.ncbi.nlm.nih.gov/16110319/)

[Reddy PH, Abnormal mitochondrial dynamics, mitochondrial fission and fusion in neurodegenerative diseases (2011)](https://pubmed.ncbi.nlm.nih.gov/21892499/)

[Kane LA, PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity (2014)](https://pubmed.ncbi.nlm.nih.gov/25416956/)

[Van Laar VS, PINK1 deficiency in neurons leads to altered mitochondrial function and morphology (2019)](https://pubmed.ncbi.nlm.nih.gov/31100568/)

[Reddy PH, Inhibitors of mitochondrial fission as a therapeutic strategy for neurodegenerative diseases (2014)](https://pubmed.ncbi.nlm.nih.gov/24635933/)

[Chen W, Mitochondrial dynamics in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32731077/)

[Rodriguez-Rodriguez P, Mitochondrial fission and neurite remodeling (2013)](https://pubmed.ncbi.nlm.nih.gov/24065096/)